TCT 2023
Insightful data and science from the Transcatheter Cardiovascular Therapeutics (TCT) 2023 conference, the annual meeting from the Cardiovascular Research Foundation, taking place October 23-26, 2023, in San Francisco, CA.
Dr. Lichaa details his presentation from TCT 2023, which covers tips and tricks for dealing with peripheral challenges.
In low-risk patients with symptomatic AS, TAVR is safe, effective, and durable up to 5 years.
Dr. Nabil Dib discusses his UltraNav Transseptal Catheter System.
Patients with severe aortic stenosis who have low surgical risk have better outcomes using TAVR compared with SAVR.
Researchers analyzed the long-term impact of TAVR on coronary arteries and cardiac hemodynamics.
A combination therapy of a statin and ezetimibe significantly reduces cardiovascular events in patients undergoing PCI.
Advertisement
Advertisement
